RightEye
PrivateLast Round
Debt
Mar 16, 2020
Total Funding Raised
$10.86M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
RightEye operates in Healthcare & Life Sciences and is based in Bethesda, Maryland. Its latest recorded funding round was a Debt round in March 2020.
RightEye is a health technology company that has developed an eye-tracking technology designed to measure visual performance and track health issues.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Computer Vision, Healthcare Analytics, Medical AI, Sports & Fitness
Business Model
B2B
Customer Profile
Hardware + Subscription, Usage-Based SaaS
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RightEye Comparables
Compare RightEye with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeuroSync | 84% | |
| EyeGuide, Inc. | 84% | |
| WIVI Vision | 82% |
For institutional investors. Book with your work email.
RightEye Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Mar 16, 2020 | ||||
| VC Round | Nov 13, 2018 | ||||
| Series A | Sep 11, 2017 | ||||
| Seed | Mar 17, 2016 | ||||
| Angel | May 14, 2013 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 65% MoM, reaching 7.8K.
- Jul 20, 2026
Open roles increased to 11, 69% of headcount.
For institutional investors. Book with your work email.
RightEye Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RightEye's valuation, stock price, and market status.
Is RightEye a public or private company?
RightEye is a private company.
What is the current stock price of RightEye?
RightEye is a private company, so its shares have no public market price. Caplight tracks RightEye's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RightEye worth (valuation)?
Valuation information for RightEye is not publicly available.
Can I buy RightEye stock?
RightEye shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RightEye's last funding round?
RightEye's most recent funding round was Debt on March 16, 2020.
Who are the main investors in RightEye?
Investor information for RightEye is not publicly disclosed.
Will RightEye IPO soon?
No public IPO plans have been announced for RightEye.
How can I track RightEye secondary market activity?
Caplight tracks bids, offers, and trades in RightEye's shares on secondary markets.